Researchers identify potential drug targets for future heart failure therapeutics

by

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes—heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).

Leave A Comment

Your email address will not be published. Required fields are marked *